Apex Healthcare Berhad (7090.KL)
MYR 2.46
(0.0%)
MYR 2.46
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 65.19 Million | 72.07 Million | 61.81 Million | 85.48 Million | 68.3 Million |
| Net Income | 423.3 Million | 120.35 Million | 75.41 Million | 70.17 Million | 52.74 Million |
| Depreciation & Amortization | 18.06 Million | 16.45 Million | 16.33 Million | 16.44 Million | 15.66 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 752.27 Thousand | 641.15 Thousand | 671.35 Thousand | 716.38 Thousand | 787.25 Thousand |
| Change in working capital | -14.55 Million | -17.59 Million | -9.82 Million | 20.34 Million | -1.92 Million |
| Other non-cash items | -6.29 Million | -853.27 Thousand | -962.06 Thousand | -643.21 Thousand | 1.02 Million |
| Investing Cash Flow | 198.45 Million | 48.01 Million | -14.88 Million | -51.49 Million | -45.05 Million |
| Investments in PPE | -28 Million | -31.92 Million | -12.14 Million | -15.85 Million | -14.46 Million |
| Acquisitions | -3.96 Million | - | - | - | - |
| Investment purchases | -871.97 Thousand | -333.65 Thousand | -3.9 Million | -37.39 Million | - |
| Sales/Maturities of investments | 7.31 Million | 80.24 Million | - | - | - |
| Other Investing Activities | 224.38 Million | 78.41 Million | -3.84 Million | -35.34 Million | -30.58 Million |
| Financing Cash Flow | -48.91 Million | -62.54 Million | -31.09 Million | -18.84 Million | -16.12 Million |
| Debt repayment | -5.85 Million | -5.85 Million | -5.85 Million | -2.92 Million | -7.07 Million |
| Dividends payments | -44.28 Million | -57.25 Million | -25.22 Million | -17.53 Million | -16.26 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2.62 Million | 2.11 Million | 1.59 Million | 3.57 Million | - |
| Other Financing Activities | 2.06 Million | 1.26 Million | 992.64 Thousand | 2.5 Million | 6.77 Million |
| Accounts receivables | -13.02 Million | -19.21 Million | -30.59 Million | 25.13 Million | -1.37 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -17.11 Million | -15.6 Million | -4.77 Million | -6.15 Million | -5.32 Million |
| Other working capital | 15.58 Million | - | - | 3.77 Million | 4.77 Million |
| Cash at beginning of period | 164.51 Million | 103.86 Million | 86.63 Million | 71.49 Million | 64.24 Million |
| Cash at end of period | 380.32 Million | 164.51 Million | 103.86 Million | 86.63 Million | 71.49 Million |
| Capital Expenditure | -28 Million | -31.92 Million | -12.14 Million | -15.85 Million | -14.46 Million |
| Effect of forex changes on cash | 1.07 Million | 3.1 Million | 1.39 Million | -8426.00 | 119.78 Thousand |
| Net cash flow / Change in cash | 215.8 Million | 60.65 Million | 17.22 Million | 15.14 Million | 7.24 Million |
| Free Cash Flow | 37.19 Million | 40.14 Million | 49.67 Million | 69.63 Million | 53.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.08 Million | 26.29 Million | 28.63 Million | 423.3 Million | 30.47 Million | 334.52 Million |
| Depreciation & Amortization | 5.3 Million | 4.91 Million | 4.71 Million | 18.06 Million | 4.5 Million | 4.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 186 Thousand | 176 Thousand | 186.27 Thousand | 752.27 Thousand | 268 Thousand | 158 Thousand |
| Change in working capital | -20.85 Million | -23.36 Million | 11.31 Million | -14.55 Million | 20 Thousand | -2.72 Million |
| Other non-cash items | -2.22 Million | -2.72 Million | -2.89 Million | -6.29 Million | -2.53 Million | -524 Thousand |
| Investing Cash Flow | -12.91 Million | 807 Thousand | -9.41 Million | 198.45 Million | 3.93 Million | 211.03 Million |
| Investments in PPE | -15.86 Million | -3.17 Million | -13.9 Million | -28 Million | -3.74 Million | -6.6 Million |
| Acquisitions | - | - | - | -3.96 Million | - | - |
| Investment purchases | - | - | -729.97 Thousand | -871.97 Thousand | 108 Thousand | -197 Thousand |
| Sales/Maturities of investments | - | - | 2.44 Million | 7.31 Million | 4.86 Million | - |
| Other Investing Activities | 2.94 Million | 3.98 Million | 2.42 Million | 224.38 Million | 7.68 Million | 217.63 Million |
| Financing Cash Flow | -162.44 Million | -1.39 Million | -1.4 Million | -48.91 Million | -19.6 Million | -26.24 Million |
| Debt repayment | -1.46 Million | -1.46 Million | -1.46 Million | -5.85 Million | -1.46 Million | -1.46 Million |
| Dividends payments | -161.92 Million | - | -121.00 | -44.28 Million | -17.95 Million | -26.32 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.48 Million | 399 Thousand | 429.62 Thousand | 2.62 Million | 125 Thousand | 1.89 Million |
| Other Financing Activities | 1.46 Million | 360 Thousand | 78.27 Thousand | 2.06 Million | 66 Thousand | 1.82 Million |
| Accounts receivables | -994 Thousand | -8.99 Million | 2.31 Million | -13.02 Million | -4.42 Million | 17.53 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 1.92 Million | -9.64 Million | 7.15 Million | -17.11 Million | -6.1 Million | -14 Million |
| Other working capital | -21.78 Million | - | - | - | - | - |
| Cash at beginning of period | 384.26 Million | 380.32 Million | 375.36 Million | 164.51 Million | 366.46 Million | 160.14 Million |
| Cash at end of period | 214.33 Million | 384.26 Million | 380.32 Million | 380.32 Million | 375.36 Million | 366.46 Million |
| Capital Expenditure | -15.86 Million | -3.17 Million | -13.9 Million | -28 Million | -3.74 Million | -6.6 Million |
| Effect of forex changes on cash | 115 Thousand | 2.29 Million | -462.38 Thousand | 1.07 Million | 1.53 Million | - |
| Net cash flow / Change in cash | -169.93 Million | 3.94 Million | 4.95 Million | 215.8 Million | 8.9 Million | 206.31 Million |
| Free Cash Flow | -10.55 Million | -946 Thousand | 2.33 Million | 37.19 Million | 19.28 Million | 14.92 Million |
9051
IRLTF
6408
SEATW
NDASEC
TNC